Global Peptide CDMO Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 132662
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.

CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.

According to our latest study, the global Peptide CDMO market size was valued at USD 2369.8 million in 2022 and is forecast to a readjusted size of USD 6106.7 million by 2029 with a CAGR of 14.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Bachem is the largest player of global peptide CDMO market, holds a share over 20%, other key players include PolyPeptide, AmbioPharm, and USV Peptides, etc. In terms of type, APIs and intermediates type is the largest segment, with a share about 60%, and in terms of application, the commercial segment holds share about 80 percent.

This report is a detailed and comprehensive analysis for global Peptide CDMO market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Peptide CDMO market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029

Global Peptide CDMO market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029

Global Peptide CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029

Global Peptide CDMO market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Peptide CDMO

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Peptide CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, PolyPeptide, AmbioPharm, USV Peptides and Thermo Fisher, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Peptide CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

APIs and Intermediates

FDF

Market segment by Application

Commercial

Academic Research

Major players covered

Bachem

PolyPeptide

AmbioPharm

USV Peptides

Thermo Fisher

Bio Basic

JPT

Genscript

Xinbang Pharma

ScinoPharm

SN Biopharm

CBL

Piramal Pharma

CordenPharma

CPC Scientific

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Peptide CDMO product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Peptide CDMO, with price, sales, revenue and global market share of Peptide CDMO from 2018 to 2023.

Chapter 3, the Peptide CDMO competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Peptide CDMO breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Peptide CDMO market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Peptide CDMO.

Chapter 14 and 15, to describe Peptide CDMO sales channel, distributors, customers, research findings and conclusion.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Peptide CDMO

1.2 Market Estimation Caveats and Base Year

1.3 Market Analysis by Type

1.3.1 Overview: Global Peptide CDMO Consumption Value by Type: 2018 Versus 2022 Versus 2029

1.3.2 APIs and Intermediates

1.3.3 FDF

1.4 Market Analysis by Application

1.4.1 Overview: Global Peptide CDMO Consumption Value by Application: 2018 Versus 2022 Versus 2029

1.4.2 Commercial

1.4.3 Academic Research

1.5 Global Peptide CDMO Market Size & Forecast

1.5.1 Global Peptide CDMO Consumption Value (2018 & 2022 & 2029)

1.5.2 Global Peptide CDMO Sales Quantity (2018-2029)

1.5.3 Global Peptide CDMO Average Price (2018-2029)

2 Manufacturers Profiles

2.1 Bachem

2.1.1 Bachem Details

2.1.2 Bachem Major Business

2.1.3 Bachem Peptide CDMO Product and Services

2.1.4 Bachem Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Bachem Recent Developments/Updates

2.2 PolyPeptide

2.2.1 PolyPeptide Details

2.2.2 PolyPeptide Major Business

2.2.3 PolyPeptide Peptide CDMO Product and Services

2.2.4 PolyPeptide Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 PolyPeptide Recent Developments/Updates

2.3 AmbioPharm

2.3.1 AmbioPharm Details

2.3.2 AmbioPharm Major Business

2.3.3 AmbioPharm Peptide CDMO Product and Services

2.3.4 AmbioPharm Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 AmbioPharm Recent Developments/Updates

2.4 USV Peptides

2.4.1 USV Peptides Details

2.4.2 USV Peptides Major Business

2.4.3 USV Peptides Peptide CDMO Product and Services

2.4.4 USV Peptides Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 USV Peptides Recent Developments/Updates

2.5 Thermo Fisher

2.5.1 Thermo Fisher Details

2.5.2 Thermo Fisher Major Business

2.5.3 Thermo Fisher Peptide CDMO Product and Services

2.5.4 Thermo Fisher Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 Thermo Fisher Recent Developments/Updates

2.6 Bio Basic

2.6.1 Bio Basic Details

2.6.2 Bio Basic Major Business

2.6.3 Bio Basic Peptide CDMO Product and Services

2.6.4 Bio Basic Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 Bio Basic Recent Developments/Updates

2.7 JPT

2.7.1 JPT Details

2.7.2 JPT Major Business

2.7.3 JPT Peptide CDMO Product and Services

2.7.4 JPT Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 JPT Recent Developments/Updates

2.8 Genscript

2.8.1 Genscript Details

2.8.2 Genscript Major Business

2.8.3 Genscript Peptide CDMO Product and Services

2.8.4 Genscript Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 Genscript Recent Developments/Updates

2.9 Xinbang Pharma

2.9.1 Xinbang Pharma Details

2.9.2 Xinbang Pharma Major Business

2.9.3 Xinbang Pharma Peptide CDMO Product and Services

2.9.4 Xinbang Pharma Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 Xinbang Pharma Recent Developments/Updates

2.10 ScinoPharm

2.10.1 ScinoPharm Details

2.10.2 ScinoPharm Major Business

2.10.3 ScinoPharm Peptide CDMO Product and Services

2.10.4 ScinoPharm Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 ScinoPharm Recent Developments/Updates

2.11 SN Biopharm

2.11.1 SN Biopharm Details

2.11.2 SN Biopharm Major Business

2.11.3 SN Biopharm Peptide CDMO Product and Services

2.11.4 SN Biopharm Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 SN Biopharm Recent Developments/Updates

2.12 CBL

2.12.1 CBL Details

2.12.2 CBL Major Business

2.12.3 CBL Peptide CDMO Product and Services

2.12.4 CBL Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 CBL Recent Developments/Updates

2.13 Piramal Pharma

2.13.1 Piramal Pharma Details

2.13.2 Piramal Pharma Major Business

2.13.3 Piramal Pharma Peptide CDMO Product and Services

2.13.4 Piramal Pharma Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.13.5 Piramal Pharma Recent Developments/Updates

2.14 CordenPharma

2.14.1 CordenPharma Details

2.14.2 CordenPharma Major Business

2.14.3 CordenPharma Peptide CDMO Product and Services

2.14.4 CordenPharma Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.14.5 CordenPharma Recent Developments/Updates

2.15 CPC Scientific

2.15.1 CPC Scientific Details

2.15.2 CPC Scientific Major Business

2.15.3 CPC Scientific Peptide CDMO Product and Services

2.15.4 CPC Scientific Peptide CDMO Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.15.5 CPC Scientific Recent Developments/Updates

3 Competitive Environment: Peptide CDMO by Manufacturer

3.1 Global Peptide CDMO Sales Quantity by Manufacturer (2018-2023)

3.2 Global Peptide CDMO Revenue by Manufacturer (2018-2023)

3.3 Global Peptide CDMO Average Price by Manufacturer (2018-2023)

3.4 Market Share Analysis (2022)

3.4.1 Producer Shipments of Peptide CDMO by Manufacturer Revenue ($MM) and Market Share (%): 2022

3.4.2 Top 3 Peptide CDMO Manufacturer Market Share in 2022

3.4.2 Top 6 Peptide CDMO Manufacturer Market Share in 2022

3.5 Peptide CDMO Market: Overall Company Footprint Analysis

3.5.1 Peptide CDMO Market: Region Footprint

3.5.2 Peptide CDMO Market: Company Product Type Footprint

3.5.3 Peptide CDMO Market: Company Product Application Footprint

3.6 New Market Entrants and Barriers to Market Entry

3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Peptide CDMO Market Size by Region

4.1.1 Global Peptide CDMO Sales Quantity by Region (2018-2029)

4.1.2 Global Peptide CDMO Consumption Value by Region (2018-2029)

4.1.3 Global Peptide CDMO Average Price by Region (2018-2029)

4.2 North America Peptide CDMO Consumption Value (2018-2029)

4.3 Europe Peptide CDMO Consumption Value (2018-2029)

4.4 Asia-Pacific Peptide CDMO Consumption Value (2018-2029)

4.5 South America Peptide CDMO Consumption Value (2018-2029)

4.6 Middle East and Africa Peptide CDMO Consumption Value (2018-2029)

5 Market Segment by Type

5.1 Global Peptide CDMO Sales Quantity by Type (2018-2029)

5.2 Global Peptide CDMO Consumption Value by Type (2018-2029)

5.3 Global Peptide CDMO Average Price by Type (2018-2029)

6 Market Segment by Application

6.1 Global Peptide CDMO Sales Quantity by Application (2018-2029)

6.2 Global Peptide CDMO Consumption Value by Application (2018-2029)

6.3 Global Peptide CDMO Average Price by Application (2018-2029)

7 North America

7.1 North America Peptide CDMO Sales Quantity by Type (2018-2029)

7.2 North America Peptide CDMO Sales Quantity by Application (2018-2029)

7.3 North America Peptide CDMO Market Size by Country

7.3.1 North America Peptide CDMO Sales Quantity by Country (2018-2029)

7.3.2 North America Peptide CDMO Consumption Value by Country (2018-2029)

7.3.3 United States Market Size and Forecast (2018-2029)

7.3.4 Canada Market Size and Forecast (2018-2029)

7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

8.1 Europe Peptide CDMO Sales Quantity by Type (2018-2029)

8.2 Europe Peptide CDMO Sales Quantity by Application (2018-2029)

8.3 Europe Peptide CDMO Market Size by Country

8.3.1 Europe Peptide CDMO Sales Quantity by Country (2018-2029)

8.3.2 Europe Peptide CDMO Consumption Value by Country (2018-2029)

8.3.3 Germany Market Size and Forecast (2018-2029)

8.3.4 France Market Size and Forecast (2018-2029)

8.3.5 United Kingdom Market Size and Forecast (2018-2029)

8.3.6 Russia Market Size and Forecast (2018-2029)

8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

9.1 Asia-Pacific Peptide CDMO Sales Quantity by Type (2018-2029)

9.2 Asia-Pacific Peptide CDMO Sales Quantity by Application (2018-2029)

9.3 Asia-Pacific Peptide CDMO Market Size by Region

9.3.1 Asia-Pacific Peptide CDMO Sales Quantity by Region (2018-2029)

9.3.2 Asia-Pacific Peptide CDMO Consumption Value by Region (2018-2029)

9.3.3 China Market Size and Forecast (2018-2029)

9.3.4 Japan Market Size and Forecast (2018-2029)

9.3.5 Korea Market Size and Forecast (2018-2029)

9.3.6 India Market Size and Forecast (2018-2029)

9.3.7 Southeast Asia Market Size and Forecast (2018-2029)

9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

10.1 South America Peptide CDMO Sales Quantity by Type (2018-2029)

10.2 South America Peptide CDMO Sales Quantity by Application (2018-2029)

10.3 South America Peptide CDMO Market Size by Country

10.3.1 South America Peptide CDMO Sales Quantity by Country (2018-2029)

10.3.2 South America Peptide CDMO Consumption Value by Country (2018-2029)

10.3.3 Brazil Market Size and Forecast (2018-2029)

10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

11.1 Middle East & Africa Peptide CDMO Sales Quantity by Type (2018-2029)

11.2 Middle East & Africa Peptide CDMO Sales Quantity by Application (2018-2029)

11.3 Middle East & Africa Peptide CDMO Market Size by Country

11.3.1 Middle East & Africa Peptide CDMO Sales Quantity by Country (2018-2029)

11.3.2 Middle East & Africa Peptide CDMO Consumption Value by Country (2018-2029)

11.3.3 Turkey Market Size and Forecast (2018-2029)

11.3.4 Egypt Market Size and Forecast (2018-2029)

11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)

11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

12.1 Peptide CDMO Market Drivers

12.2 Peptide CDMO Market Restraints

12.3 Peptide CDMO Trends Analysis

12.4 Porters Five Forces Analysis

12.4.1 Threat of New Entrants

12.4.2 Bargaining Power of Suppliers

12.4.3 Bargaining Power of Buyers

12.4.4 Threat of Substitutes

12.4.5 Competitive Rivalry

12.5 Influence of COVID-19 and Russia-Ukraine War

12.5.1 Influence of COVID-19

12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

13.1 Raw Material of Peptide CDMO and Key Manufacturers

13.2 Manufacturing Costs Percentage of Peptide CDMO

13.3 Peptide CDMO Production Process

13.4 Peptide CDMO Industrial Chain

14 Shipments by Distribution Channel

14.1 Sales Channel

14.1.1 Direct to End-User

14.1.2 Distributors

14.2 Peptide CDMO Typical Distributors

14.3 Peptide CDMO Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology

16.2 Research Process and Data Source

16.3 Disclaimer

List of Tables

Table 1. Global Peptide CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Peptide CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Bachem Basic Information, Manufacturing Base and Competitors

Table 4. Bachem Major Business

Table 5. Bachem Peptide CDMO Product and Services

Table 6. Bachem Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 7. Bachem Recent Developments/Updates

Table 8. PolyPeptide Basic Information, Manufacturing Base and Competitors

Table 9. PolyPeptide Major Business

Table 10. PolyPeptide Peptide CDMO Product and Services

Table 11. PolyPeptide Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 12. PolyPeptide Recent Developments/Updates

Table 13. AmbioPharm Basic Information, Manufacturing Base and Competitors

Table 14. AmbioPharm Major Business

Table 15. AmbioPharm Peptide CDMO Product and Services

Table 16. AmbioPharm Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 17. AmbioPharm Recent Developments/Updates

Table 18. USV Peptides Basic Information, Manufacturing Base and Competitors

Table 19. USV Peptides Major Business

Table 20. USV Peptides Peptide CDMO Product and Services

Table 21. USV Peptides Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 22. USV Peptides Recent Developments/Updates

Table 23. Thermo Fisher Basic Information, Manufacturing Base and Competitors

Table 24. Thermo Fisher Major Business

Table 25. Thermo Fisher Peptide CDMO Product and Services

Table 26. Thermo Fisher Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 27. Thermo Fisher Recent Developments/Updates

Table 28. Bio Basic Basic Information, Manufacturing Base and Competitors

Table 29. Bio Basic Major Business

Table 30. Bio Basic Peptide CDMO Product and Services

Table 31. Bio Basic Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 32. Bio Basic Recent Developments/Updates

Table 33. JPT Basic Information, Manufacturing Base and Competitors

Table 34. JPT Major Business

Table 35. JPT Peptide CDMO Product and Services

Table 36. JPT Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 37. JPT Recent Developments/Updates

Table 38. Genscript Basic Information, Manufacturing Base and Competitors

Table 39. Genscript Major Business

Table 40. Genscript Peptide CDMO Product and Services

Table 41. Genscript Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 42. Genscript Recent Developments/Updates

Table 43. Xinbang Pharma Basic Information, Manufacturing Base and Competitors

Table 44. Xinbang Pharma Major Business

Table 45. Xinbang Pharma Peptide CDMO Product and Services

Table 46. Xinbang Pharma Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 47. Xinbang Pharma Recent Developments/Updates

Table 48. ScinoPharm Basic Information, Manufacturing Base and Competitors

Table 49. ScinoPharm Major Business

Table 50. ScinoPharm Peptide CDMO Product and Services

Table 51. ScinoPharm Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 52. ScinoPharm Recent Developments/Updates

Table 53. SN Biopharm Basic Information, Manufacturing Base and Competitors

Table 54. SN Biopharm Major Business

Table 55. SN Biopharm Peptide CDMO Product and Services

Table 56. SN Biopharm Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 57. SN Biopharm Recent Developments/Updates

Table 58. CBL Basic Information, Manufacturing Base and Competitors

Table 59. CBL Major Business

Table 60. CBL Peptide CDMO Product and Services

Table 61. CBL Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 62. CBL Recent Developments/Updates

Table 63. Piramal Pharma Basic Information, Manufacturing Base and Competitors

Table 64. Piramal Pharma Major Business

Table 65. Piramal Pharma Peptide CDMO Product and Services

Table 66. Piramal Pharma Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 67. Piramal Pharma Recent Developments/Updates

Table 68. CordenPharma Basic Information, Manufacturing Base and Competitors

Table 69. CordenPharma Major Business

Table 70. CordenPharma Peptide CDMO Product and Services

Table 71. CordenPharma Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 72. CordenPharma Recent Developments/Updates

Table 73. CPC Scientific Basic Information, Manufacturing Base and Competitors

Table 74. CPC Scientific Major Business

Table 75. CPC Scientific Peptide CDMO Product and Services

Table 76. CPC Scientific Peptide CDMO Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 77. CPC Scientific Recent Developments/Updates

Table 78. Global Peptide CDMO Sales Quantity by Manufacturer (2018-2023) & (Tons)

Table 79. Global Peptide CDMO Revenue by Manufacturer (2018-2023) & (USD Million)

Table 80. Global Peptide CDMO Average Price by Manufacturer (2018-2023) & (US$/Ton)

Table 81. Market Position of Manufacturers in Peptide CDMO, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022

Table 82. Head Office and Peptide CDMO Production Site of Key Manufacturer

Table 83. Peptide CDMO Market: Company Product Type Footprint

Table 84. Peptide CDMO Market: Company Product Application Footprint

Table 85. Peptide CDMO New Market Entrants and Barriers to Market Entry

Table 86. Peptide CDMO Mergers, Acquisition, Agreements, and Collaborations

Table 87. Global Peptide CDMO Sales Quantity by Region (2018-2023) & (Tons)

Table 88. Global Peptide CDMO Sales Quantity by Region (2024-2029) & (Tons)

Table 89. Global Peptide CDMO Consumption Value by Region (2018-2023) & (USD Million)

Table 90. Global Peptide CDMO Consumption Value by Region (2024-2029) & (USD Million)

Table 91. Global Peptide CDMO Average Price by Region (2018-2023) & (US$/Ton)

Table 92. Global Peptide CDMO Average Price by Region (2024-2029) & (US$/Ton)

Table 93. Global Peptide CDMO Sales Quantity by Type (2018-2023) & (Tons)

Table 94. Global Peptide CDMO Sales Quantity by Type (2024-2029) & (Tons)

Table 95. Global Peptide CDMO Consumption Value by Type (2018-2023) & (USD Million)

Table 96. Global Peptide CDMO Consumption Value by Type (2024-2029) & (USD Million)

Table 97. Global Peptide CDMO Average Price by Type (2018-2023) & (US$/Ton)

Table 98. Global Peptide CDMO Average Price by Type (2024-2029) & (US$/Ton)

Table 99. Global Peptide CDMO Sales Quantity by Application (2018-2023) & (Tons)

Table 100. Global Peptide CDMO Sales Quantity by Application (2024-2029) & (Tons)

Table 101. Global Peptide CDMO Consumption Value by Application (2018-2023) & (USD Million)

Table 102. Global Peptide CDMO Consumption Value by Application (2024-2029) & (USD Million)

Table 103. Global Peptide CDMO Average Price by Application (2018-2023) & (US$/Ton)

Table 104. Global Peptide CDMO Average Price by Application (2024-2029) & (US$/Ton)

Table 105. North America Peptide CDMO Sales Quantity by Type (2018-2023) & (Tons)

Table 106. North America Peptide CDMO Sales Quantity by Type (2024-2029) & (Tons)

Table 107. North America Peptide CDMO Sales Quantity by Application (2018-2023) & (Tons)

Table 108. North America Peptide CDMO Sales Quantity by Application (2024-2029) & (Tons)

Table 109. North America Peptide CDMO Sales Quantity by Country (2018-2023) & (Tons)

Table 110. North America Peptide CDMO Sales Quantity by Country (2024-2029) & (Tons)

Table 111. North America Peptide CDMO Consumption Value by Country (2018-2023) & (USD Million)

Table 112. North America Peptide CDMO Consumption Value by Country (2024-2029) & (USD Million)

Table 113. Europe Peptide CDMO Sales Quantity by Type (2018-2023) & (Tons)

Table 114. Europe Peptide CDMO Sales Quantity by Type (2024-2029) & (Tons)

Table 115. Europe Peptide CDMO Sales Quantity by Application (2018-2023) & (Tons)

Table 116. Europe Peptide CDMO Sales Quantity by Application (2024-2029) & (Tons)

Table 117. Europe Peptide CDMO Sales Quantity by Country (2018-2023) & (Tons)

Table 118. Europe Peptide CDMO Sales Quantity by Country (2024-2029) & (Tons)

Table 119. Europe Peptide CDMO Consumption Value by Country (2018-2023) & (USD Million)

Table 120. Europe Peptide CDMO Consumption Value by Country (2024-2029) & (USD Million)

Table 121. Asia-Pacific Peptide CDMO Sales Quantity by Type (2018-2023) & (Tons)

Table 122. Asia-Pacific Peptide CDMO Sales Quantity by Type (2024-2029) & (Tons)

Table 123. Asia-Pacific Peptide CDMO Sales Quantity by Application (2018-2023) & (Tons)

Table 124. Asia-Pacific Peptide CDMO Sales Quantity by Application (2024-2029) & (Tons)

Table 125. Asia-Pacific Peptide CDMO Sales Quantity by Region (2018-2023) & (Tons)

Table 126. Asia-Pacific Peptide CDMO Sales Quantity by Region (2024-2029) & (Tons)

Table 127. Asia-Pacific Peptide CDMO Consumption Value by Region (2018-2023) & (USD Million)

Table 128. Asia-Pacific Peptide CDMO Consumption Value by Region (2024-2029) & (USD Million)

Table 129. South America Peptide CDMO Sales Quantity by Type (2018-2023) & (Tons)

Table 130. South America Peptide CDMO Sales Quantity by Type (2024-2029) & (Tons)

Table 131. South America Peptide CDMO Sales Quantity by Application (2018-2023) & (Tons)

Table 132. South America Peptide CDMO Sales Quantity by Application (2024-2029) & (Tons)

Table 133. South America Peptide CDMO Sales Quantity by Country (2018-2023) & (Tons)

Table 134. South America Peptide CDMO Sales Quantity by Country (2024-2029) & (Tons)

Table 135. South America Peptide CDMO Consumption Value by Country (2018-2023) & (USD Million)

Table 136. South America Peptide CDMO Consumption Value by Country (2024-2029) & (USD Million)

Table 137. Middle East & Africa Peptide CDMO Sales Quantity by Type (2018-2023) & (Tons)

Table 138. Middle East & Africa Peptide CDMO Sales Quantity by Type (2024-2029) & (Tons)

Table 139. Middle East & Africa Peptide CDMO Sales Quantity by Application (2018-2023) & (Tons)

Table 140. Middle East & Africa Peptide CDMO Sales Quantity by Application (2024-2029) & (Tons)

Table 141. Middle East & Africa Peptide CDMO Sales Quantity by Region (2018-2023) & (Tons)

Table 142. Middle East & Africa Peptide CDMO Sales Quantity by Region (2024-2029) & (Tons)

Table 143. Middle East & Africa Peptide CDMO Consumption Value by Region (2018-2023) & (USD Million)

Table 144. Middle East & Africa Peptide CDMO Consumption Value by Region (2024-2029) & (USD Million)

Table 145. Peptide CDMO Raw Material

Table 146. Key Manufacturers of Peptide CDMO Raw Materials

Table 147. Peptide CDMO Typical Distributors

Table 148. Peptide CDMO Typical Customers

List of Figures

Figure 1. Peptide CDMO Picture

Figure 2. Global Peptide CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Peptide CDMO Consumption Value Market Share by Type in 2022

Figure 4. APIs and Intermediates Examples

Figure 5. FDF Examples

Figure 6. Global Peptide CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Figure 7. Global Peptide CDMO Consumption Value Market Share by Application in 2022

Figure 8. Commercial Examples

Figure 9. Academic Research Examples

Figure 10. Global Peptide CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 11. Global Peptide CDMO Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 12. Global Peptide CDMO Sales Quantity (2018-2029) & (Tons)

Figure 13. Global Peptide CDMO Average Price (2018-2029) & (US$/Ton)

Figure 14. Global Peptide CDMO Sales Quantity Market Share by Manufacturer in 2022

Figure 15. Global Peptide CDMO Consumption Value Market Share by Manufacturer in 2022

Figure 16. Producer Shipments of Peptide CDMO by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021

Figure 17. Top 3 Peptide CDMO Manufacturer (Consumption Value) Market Share in 2022

Figure 18. Top 6 Peptide CDMO Manufacturer (Consumption Value) Market Share in 2022

Figure 19. Global Peptide CDMO Sales Quantity Market Share by Region (2018-2029)

Figure 20. Global Peptide CDMO Consumption Value Market Share by Region (2018-2029)

Figure 21. North America Peptide CDMO Consumption Value (2018-2029) & (USD Million)

Figure 22. Europe Peptide CDMO Consumption Value (2018-2029) & (USD Million)

Figure 23. Asia-Pacific Peptide CDMO Consumption Value (2018-2029) & (USD Million)

Figure 24. South America Peptide CDMO Consumption Value (2018-2029) & (USD Million)

Figure 25. Middle East & Africa Peptide CDMO Consumption Value (2018-2029) & (USD Million)

Figure 26. Global Peptide CDMO Sales Quantity Market Share by Type (2018-2029)

Figure 27. Global Peptide CDMO Consumption Value Market Share by Type (2018-2029)

Figure 28. Global Peptide CDMO Average Price by Type (2018-2029) & (US$/Ton)

Figure 29. Global Peptide CDMO Sales Quantity Market Share by Application (2018-2029)

Figure 30. Global Peptide CDMO Consumption Value Market Share by Application (2018-2029)

Figure 31. Global Peptide CDMO Average Price by Application (2018-2029) & (US$/Ton)

Figure 32. North America Peptide CDMO Sales Quantity Market Share by Type (2018-2029)

Figure 33. North America Peptide CDMO Sales Quantity Market Share by Application (2018-2029)

Figure 34. North America Peptide CDMO Sales Quantity Market Share by Country (2018-2029)

Figure 35. North America Peptide CDMO Consumption Value Market Share by Country (2018-2029)

Figure 36. United States Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 37. Canada Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 38. Mexico Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 39. Europe Peptide CDMO Sales Quantity Market Share by Type (2018-2029)

Figure 40. Europe Peptide CDMO Sales Quantity Market Share by Application (2018-2029)

Figure 41. Europe Peptide CDMO Sales Quantity Market Share by Country (2018-2029)

Figure 42. Europe Peptide CDMO Consumption Value Market Share by Country (2018-2029)

Figure 43. Germany Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 44. France Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 45. United Kingdom Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 46. Russia Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 47. Italy Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 48. Asia-Pacific Peptide CDMO Sales Quantity Market Share by Type (2018-2029)

Figure 49. Asia-Pacific Peptide CDMO Sales Quantity Market Share by Application (2018-2029)

Figure 50. Asia-Pacific Peptide CDMO Sales Quantity Market Share by Region (2018-2029)

Figure 51. Asia-Pacific Peptide CDMO Consumption Value Market Share by Region (2018-2029)

Figure 52. China Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 53. Japan Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 54. Korea Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 55. India Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 56. Southeast Asia Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 57. Australia Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 58. South America Peptide CDMO Sales Quantity Market Share by Type (2018-2029)

Figure 59. South America Peptide CDMO Sales Quantity Market Share by Application (2018-2029)

Figure 60. South America Peptide CDMO Sales Quantity Market Share by Country (2018-2029)

Figure 61. South America Peptide CDMO Consumption Value Market Share by Country (2018-2029)

Figure 62. Brazil Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 63. Argentina Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 64. Middle East & Africa Peptide CDMO Sales Quantity Market Share by Type (2018-2029)

Figure 65. Middle East & Africa Peptide CDMO Sales Quantity Market Share by Application (2018-2029)

Figure 66. Middle East & Africa Peptide CDMO Sales Quantity Market Share by Region (2018-2029)

Figure 67. Middle East & Africa Peptide CDMO Consumption Value Market Share by Region (2018-2029)

Figure 68. Turkey Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 69. Egypt Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 70. Saudi Arabia Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 71. South Africa Peptide CDMO Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 72. Peptide CDMO Market Drivers

Figure 73. Peptide CDMO Market Restraints

Figure 74. Peptide CDMO Market Trends

Figure 75. Porters Five Forces Analysis

Figure 76. Manufacturing Cost Structure Analysis of Peptide CDMO in 2022

Figure 77. Manufacturing Process Analysis of Peptide CDMO

Figure 78. Peptide CDMO Industrial Chain

Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors

Figure 80. Direct Channel Pros & Cons

Figure 81. Indirect Channel Pros & Cons

Figure 82. Methodology

Figure 83. Research Process and Data Source